ProfileGDS4459 / ENSG00000162066
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 60% 65% 60% 62% 62% 61% 65% 63% 58% 56% 63% 57% 59% 73% 54% 62% 62% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.7760
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.9765
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.8160
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.9162
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.9162
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.8161
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.1465
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.9463
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.7258
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.756
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.8363
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.757
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.7959
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.3373
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.5554
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.8362
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.8162